Nonsecretory multiple myeloma.
Bourantas
K
K
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001853:Bone Marrow / Q000473:pathology; D003907:Dexamethasone; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D008875:Middle Aged; D009101:Multiple Myeloma / Q000145:classification* / Q000188:drug therapy / Q000473:pathology / Q000628:therapy; D009367:Neoplasm Staging; D010950:Plasma Cells / Q000473:pathology; D011239:Prednisolone / Q000008:administration & dosage; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D007372:Interferons; D011239:Prednisolone; D008558:Melphalan